The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
The Summer Solstice - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, June 1, 2021, with company presentations beginning at 9am Eastern Time. Presentations will be webcast on Tuesday and Wednesday (June 1 and 2) with 1x1 Meetings being held on Thursday and Friday (June 3 and 4).
Join us for a full two days of presentations that were nominated by qualified investors as a "Best Idea." A full agenda is located here: https://microcaprodeo.com/agenda
If you would like to attend and participate in the Summer Solstice - Best Ideas from the Buy-Side Virtual Conference, please register here to listen to every webcast directly on the website and book 1x1 meetings with presenting companies: https://microcaprodeo.com/signup
Full event website: https://microcaprodeo.com/
On Tuesday June 1, 2021 and Wednesday, June 2, 2021, the following issuers will be presenting their companies virtually. Below are the webcasting links to view presentations.
Date | Time | Presentation Name | Ticker | Event URL |
Tuesday, June 1st | 8:30 - 8:55 | RedHill Biopharma | RDHL | |
Tuesday, June 1st | 9:00-9:25 | Photocure | PHO | |
Tuesday, June 1st | 9:30-9:55 | electroCure | ECOR | |
Tuesday, June 1st | 10:00-10:25 | Mechanical Technology, Inc. | MKTY | |
Tuesday, June 1st | 10:30-10:55 | Stabillis Solutions, Inc. | SLNG | |
Tuesday, June 1st | 11:00-11:25 | CECO Environmental Corp | CECE | |
Tuesday, June 1st | 11:30-11:55 | Monaker Group | MKGI | |
Tuesday, June 1st | 12:00-12:25 | Auddia Inc. | AUUD | |
Tuesday, June 1st | 12:30-12:55 | Assure Holdings | ARHH | |
Tuesday, June 1st | 1:00-1:25 | Dolphin Entertainment | DLPN | |
Tuesday, June 1st | 1:30-1:55 | IMAC Holdings | IMAC | |
Tuesday, June 1st | 2:00-2:25 | COMSovereign | COMS | |
Tuesday, June 1st | 2:30-2:55 | Myomo | MYO | |
Tuesday, June 1st | 3:00-3:25 | Pivotal Systems | PVS | |
Tuesday, June 1st | 3:30-3:55 | Miravo Healthcare | MRVFF | |
Tuesday, June 1st | 4:00-4:25 | NZME | NZME | |
Tuesday, June 1st | 4:30-4:55 | Zoom Telephonics dba Minim | MINM | |
Tuesday, June 1st | 5:00 - 5:25 | DataStorage Corp | DTST | |
Wednesday, June 2nd | 8:30-8:55 | NLS Pharmaceuticals | NLSP | |
Wednesday, June 2nd | 9:00-9:25 | Aspira Women's Health | AWH | |
Wednesday, June 2nd | 9:30-9:55 | Issuer Direct (ISDR) | ISDR | |
Wednesday, June 2nd | 10:00-10:25 | Biomerica | BMRA | |
Wednesday, June 2nd | 10:30-10:55 | Alimera Sciences | ALIM | |
Wednesday, June 2nd | 11:00-11:25 | LifeMD | LFMD | |
Wednesday, June 2nd | 11:30-11:55 | Stryve Foods, LLC | ANDA | |
Wednesday, June 2nd | 12:00-12:25 | Biolase | BIOL | |
Wednesday, June 2nd | 12:30-12:55 | CloudCall Group | CALL:L | |
Wednesday, June 2nd | 1:00-1:25 | Fortress Biotech | FBIO | |
Wednesday, June 2nd | 1:30-1:55 | DHI Group | DHX | |
Wednesday, June 2nd | 2:00-2:25 | Milestone Scientific | MLSS | |
Wednesday, June 2nd | 2:30-2:55 | Orgenesis | ORGS | |
Wednesday, June 2nd | 3:00-3:25 | Elys Game Technology Corp | ELYS | |
Wednesday, June 2nd | 3:30-3:55 | Thunderbird Entertainment | THBRF | |
Wednesday, June 2nd | 4:00-4:25 | Nemaura Medical | NMRD | |
Wednesday, June 2nd | 4:30-4:55 | Daxor | DXR |
Contact Information:
Angie Goertz, Vice President of Marketing
Issuer Direct Corporation
Office: (919) 228-6240
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$7.00 |
| Daily Change: | -0.16 -2.23 |
| Daily Volume: | 22,579 |
| Market Cap: | US$8.960M |
October 28, 2024 October 01, 2024 September 30, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
